Sequence vs Hims for GLP-1 Weight Loss: Brand vs Price

Compare Sequence vs Hims for GLP-1 weight loss medications. Detailed analysis of pricing, doctor quality, and patient experience. Find the best option...

By FormBlends Editorial Research|Source reviewed by FormBlends Medical Team|Last reviewed April 1, 2026|Published December 29, 2025

Source Reviewed

Written by FormBlends Editorial Research · Checked against primary sources by FormBlends Medical Team

This article is part of our Provider Comparisons collection. See also: GLP-1 Guides | Peptide Guides

Sequence (formerly WeightWatchers) and Hims represent two different approaches to GLP-1 weight loss therapy: established brand recognition versus competitive pricing. Both platforms offer telehealth access to semaglutide and tirzepatide, but their pricing structures, medication sourcing, and patient support models differ significantly.

This comparison examines real costs, medication availability, physician oversight quality, and patient experience data to help you choose the right platform for your weight loss process. We'll analyze verified pricing from both companies' websites, review their consultation processes, and evaluate which option delivers better value for different patient profiles.

Sequence: What You Get

Sequence, the medical weight loss arm of WeightWatchers, positions itself as a thorough lifestyle platform combining GLP-1 medications with behavioral coaching. The service launched in 2023, using WeightWatchers' decades of weight management experience to create a medically-supervised program.

Pricing Structure: Sequence charges $297 per month for their complete program, which includes medication, physician consultations, and access to WeightWatchers' digital platform. This pricing covers both semaglutide and tirzepatide options, with no additional fees for dose adjustments or medication switches. The company requires a three-month minimum commitment, bringing the initial investment to $891.

Medication Access: Sequence offers compounded semaglutide starting at 0.25mg weekly doses, with escalation protocols following FDA-approved guidelines. Tirzepatide is available starting at 2.5mg weekly. All medications are sourced from FDA-registered 503B compounding pharmacies, with certificates of analysis available upon request. The platform provides both medications in pre-filled syringes, eliminating the need for patients to draw doses from vials.

Consultation Process: New patients complete a thorough health assessment covering medical history, current medications, and weight loss goals. Licensed physicians review applications within 24-48 hours. Sequence offers both video consultations and messaging-based follow-ups, with physicians available for questions throughout treatment. The platform schedules regular check-ins at 4, 8, and 12-week intervals.

Additional Features: Sequence membership includes full access to WeightWatchers' PersonalPoints system, recipe database, and community forums. Patients receive nutritional guidance, meal planning tools, and behavioral coaching resources. The platform tracks weight loss progress and provides data visualization tools for monitoring trends.

Shipping and Logistics: Medications ship via FedEx with temperature-controlled packaging. Standard delivery takes 5-7 business days, with expedited options available for additional fees. Sequence provides detailed storage instructions and disposal kits for used syringes.

Pros:

• thorough lifestyle support beyond medication
• Video consultation options with physicians
• Integration with established WeightWatchers ecosystem
• Pre-filled syringes for convenience
• Regular physician monitoring

Cons:

• Higher monthly cost compared to competitors
• Three-month minimum commitment required
• Longer shipping times than some alternatives
• Limited flexibility in dosing schedules

Hims: What You Get

Hims entered the GLP-1 weight loss market in 2023, extending their direct-to-consumer telehealth model to include semaglutide and tirzepatide. The platform emphasizes affordability and simplified access, targeting price-conscious patients seeking straightforward medication delivery without extensive coaching programs. For a complete cost breakdown, see our affordable GLP-1 options.

Pricing Structure: Hims charges $199 per month for GLP-1 medications, representing a $98 monthly savings compared to Sequence. This price includes physician consultations, medication, and shipping. Hims operates on a month-to-month basis with no long-term commitments required. The company occasionally offers promotional pricing for new customers, with discounts reaching 20% for first-time users.

Medication Access: Hims provides compounded semaglutide and tirzepatide through partnerships with licensed compounding pharmacies. Semaglutide starts at 0.25mg weekly, following standard dose escalation protocols. Tirzepatide begins at 2.5mg weekly. Medications arrive in multi-dose vials requiring patients to draw their own injections using provided syringes. The company includes detailed injection tutorials and technique videos.

Consultation Process: The Hims onboarding process centers around a digital health questionnaire covering medical history, current medications, and weight loss goals. Licensed physicians review applications and approve treatment plans, typically within 24 hours. Follow-up consultations occur primarily through the platform's messaging system, with physicians available for questions during business hours.

Technology Platform: Hims operates through a mobile app and web portal allowing patients to track progress, message physicians, and manage prescriptions. The platform includes basic weight tracking tools and medication reminders. Patients can upload progress photos and receive automated check-in prompts at regular intervals.

Shipping and Logistics: Medications ship within 2-3 business days via USPS or FedEx, depending on location. Hims includes temperature monitoring stickers with shipments to ensure medication integrity. The company provides sharps disposal containers and detailed storage instructions for multi-dose vials.

Support Resources: While Hims doesn't offer thorough lifestyle coaching like Sequence, the platform provides educational content about GLP-1 medications, injection techniques, and managing side effects. Patients access a knowledge base with frequently asked questions and video tutorials.

Pros:

• Significantly lower monthly cost
• No long-term commitments required
• Fast shipping and delivery
• simplified, tech-forward experience
• Flexible month-to-month billing

Cons:

• Limited lifestyle coaching and support
• Primarily text-based physician interactions
• Multi-dose vials require self-injection preparation
• Fewer thorough tracking tools
• Limited educational resources compared to competitors

Price Comparison: Sequence vs Hims

The cost difference between Sequence and Hims represents the most significant factor for many patients. Hims charges $199 monthly compared to Sequence's $297, creating a $98 monthly difference or $1,176 annually. Over a typical 12-month treatment period, patients save $1,176 choosing Hims over Sequence.

But direct price comparisons don't account for included services. Sequence's higher cost includes WeightWatchers membership, behavioral coaching, and more thorough physician oversight. Hims focuses purely on medication access with minimal additional services. Patients must evaluate whether Sequence's additional features justify the 49% price premium.

Insurance coverage varies between platforms. Neither Sequence nor Hims currently accepts insurance for GLP-1 medications, requiring patients to pay out-of-pocket. Some patients may qualify for HSA or FSA reimbursement, but this depends on individual account terms and requires documentation of medical necessity.

Hidden costs differ between platforms. Sequence includes all shipping, syringes, and consultation fees in their monthly price. Hims also includes shipping and basic supplies, but patients requiring expedited delivery or additional physician consultations may face extra charges. Both platforms charge separately for laboratory testing if required.

Medication Options: Sequence vs Hims

Both platforms offer semaglutide and tirzepatide, the two primary GLP-1 medications for weight loss. But their sourcing, preparation, and delivery methods differ significantly, affecting patient experience and treatment outcomes.

Semaglutide Availability: Sequence provides compounded semaglutide in pre-filled syringes, starting at 0.25mg weekly doses. The medication follows standard dose escalation: 0.25mg for 4 weeks, 0.5mg for 4 weeks, then 1.0mg, 1.7mg, and 2.4mg as tolerated. Hims offers identical dosing protocols but delivers medication in multi-dose vials requiring patient preparation.

Tirzepatide Access: Both platforms provide tirzepatide starting at 2.5mg weekly, escalating to 5mg, 7.5mg, 10mg, 12.5mg, and 15mg maximum doses. Sequence delivers tirzepatide in pre-filled syringes, while Hims uses multi-dose vials. Clinical studies show tirzepatide produces superior weight loss compared to semaglutide, with average reductions of 20.9% versus 14.9% body weight^[1] respectively.

Compounding Quality: Sequence sources medications from FDA-registered 503B compounding facilities, providing certificates of analysis for each batch. Hims partners with licensed compounding pharmacies but doesn't routinely provide batch testing documentation. Both platforms follow USP 797 sterile compounding standards, though transparency levels differ.

Medication Switching: Sequence allows switching between semaglutide and tirzepatide without additional fees, with physician approval. Hims permits medication changes but may require new prescriptions and consultation fees. Patients experiencing side effects or inadequate weight loss benefit from flexible switching options.

Dosing Flexibility: Sequence follows standardized protocols with limited dose customization. Hims offers more flexible dosing schedules, allowing physicians to adjust based on individual patient response. Some patients require non-standard dosing due to side effects or efficacy concerns.

Doctor Quality and Oversight

Physician oversight quality varies significantly between Sequence and Hims, affecting patient safety, treatment improvement, and long-term success rates. Both platforms employ licensed physicians, but their involvement levels and accessibility differ substantially.

Sequence Physician Model: Sequence physicians conduct thorough initial consultations, often via video calls lasting 15-20 minutes. Doctors review medical history, discuss weight loss goals, and explain treatment protocols in detail. The platform schedules regular follow-up appointments at 4, 8, and 12-week intervals, with additional consultations available as needed. Physicians monitor progress actively and adjust dosing based on patient response and side effects.

Hims Physician Approach: Hims use a simplified consultation model focusing on medical clearance and prescription approval. Initial consultations occur primarily through digital questionnaires, with physicians reviewing responses and approving treatment plans. Follow-up interactions happen mainly through messaging, with phone consultations available upon request. The model prioritizes efficiency over thorough ongoing care.

Medical Monitoring: Sequence requires regular check-ins and progress assessments, with physicians actively tracking weight loss, side effects, and overall health metrics. The platform may recommend laboratory testing for patients with diabetes, kidney disease, or other comorbidities. Hims provides basic monitoring through patient-reported outcomes, with less proactive physician involvement in ongoing care.

Side Effect Management: GLP-1 medications commonly cause nausea, vomiting, diarrhea, and constipation, particularly during dose escalation. Sequence physicians provide detailed side effect management strategies, including dietary modifications, timing adjustments, and temporary dose reductions. Hims offers basic side effect information but relies more heavily on patient self-management.

Physician Credentials: Both platforms employ board-certified physicians licensed in patients' states. Sequence physicians often have additional training in obesity medicine or endocrinology. Hims focuses on primary care physicians with telehealth experience. Neither platform publicly discloses specific physician credentials or specializations.

Patient Experience and Reviews

Patient satisfaction data reveals distinct experiences between Sequence and Hims users, reflecting their different service models and price points. Review analysis from Trustpilot, Google Reviews, and Reddit discussions provides insight into real-world patient experiences.

Sequence Patient Feedback: Sequence users frequently praise the thorough support system, particularly the integration with WeightWatchers' lifestyle coaching. Patients report average weight loss of 12-18% over 6 months, consistent with clinical trial data for GLP-1 medications. Common complaints include high costs and slower shipping times compared to competitors. Patients appreciate the pre-filled syringes and detailed injection training provided.

Hims Patient Reviews: Hims users emphasize the platform's affordability and simplified process. Patients report satisfaction with fast shipping and responsive customer service. But some users note challenges with multi-dose vial preparation and limited physician interaction. Weight loss outcomes appear similar to Sequence, suggesting medication effectiveness remains consistent across platforms.

Customer Service Quality: Sequence provides customer support through multiple channels, including phone, email, and in-app messaging. Response times average 2-4 hours during business hours. Hims offers primarily chat and email support, with faster response times averaging 1-2 hours. Both platforms receive generally positive customer service ratings.

Treatment Discontinuation Rates: Industry data suggests 30-40% of patients discontinue GLP-1 therapy within 6 months due to side effects, cost, or inadequate weight loss. Sequence reports lower discontinuation rates, potentially due to their thorough support system and physician oversight. Hims doesn't publish specific retention data, but user reviews suggest similar discontinuation patterns.

Long-term Outcomes: Patients using either platform report significant weight loss during active treatment. But weight regain commonly occurs after discontinuation, emphasizing the importance of lifestyle modifications alongside medication therapy. Sequence's integrated behavioral coaching may provide advantages for long-term weight maintenance.

Which Is Right for You?

Choosing between Sequence and Hims depends on your priorities, budget, and support needs. Each platform serves different patient populations effectively, with distinct advantages and limitations.

Choose Sequence if you:

• Value thorough lifestyle support and behavioral coaching
• Prefer regular physician check-ins and proactive monitoring
• Want pre-filled syringes for injection convenience
• Have previous success with WeightWatchers programs
• Can afford the higher monthly cost for additional services
• Prefer video consultations with healthcare providers

Choose Hims if you:

• Prioritize affordability and cost savings
• Prefer flexible, month-to-month commitments
• Want fast medication delivery
• Are comfortable with self-injection preparation
• Prefer minimal interaction with healthcare providers
• Have experience managing chronic medications independently

For patients seeking a middle ground between thorough support and affordability, FormBlends offers physician-supervised GLP-1 therapy with competitive pricing and personalized treatment plans. Our clinical team provides ongoing support while maintaining cost-effective access to both semaglutide and tirzepatide.

Consider your long-term weight management goals when making this decision. Patients requiring extensive behavioral support may benefit from Sequence's thorough approach, while those comfortable with independent medication management may find Hims sufficient for their needs.

Frequently Asked Questions

FormBlends

FormBlends is a U.S. telehealth platform that prescribes compounded semaglutide and tirzepatide. Patients complete an online intake, a licensed provider reviews eligibility, and medication ships from a 503A compounding pharmacy. Monthly pricing starts at $199. Start your intake.

Can I switch from Sequence to Hims or vice versa?

Yes, you can switch between platforms, but you'll need a new consultation and prescription from the new provider. Ensure you have enough medication to avoid treatment gaps during the transition. Both platforms require medical clearance before starting treatment, even if you're already using GLP-1 medications.

Do either Sequence or Hims accept insurance for GLP-1 medications?

Currently, neither platform accepts insurance for GLP-1 weight loss medications. All costs are out-of-pocket. Some patients may qualify for HSA or FSA reimbursement with proper documentation from their physician. Check with your insurance provider about potential coverage for obesity treatment.

How do the weight loss results compare between Sequence and Hims?

Both platforms use the same medications (semaglutide and tirzepatide), so weight loss outcomes should be similar. Clinical studies show average weight loss of 14-21% over 6-12 months. Results depend more on medication adherence, dosing, and lifestyle factors than the specific telehealth platform.

What happens if I experience side effects with either service?

Both platforms provide side effect management, but Sequence offers more thorough support through regular physician check-ins and detailed guidance. Hims provides basic information and physician messaging for side effect concerns. Common side effects include nausea, vomiting, and digestive issues, particularly during dose increases.

Are the compounded medications from Sequence and Hims safe and effective?

Both platforms source medications from licensed compounding pharmacies following FDA regulations. Compounded semaglutide and tirzepatide contain the specified active pharmaceutical ingredients. Compounded medications are not FDA-approved as finished products. But compounded medications aren't FDA-approved and may have different purity or potency compared to branded drugs.

Ready to Start Your Weight Loss Goals?

Both Sequence and Hims offer legitimate paths to accessing GLP-1 medications for weight loss, each with distinct advantages. Sequence provides thorough support at a premium price, while Hims focuses on affordable, simplified access.

For patients seeking physician-supervised care with competitive pricing, FormBlends combines clinical expertise with personalized treatment plans. Our approach emphasizes ongoing medical oversight while maintaining cost-effective access to proven weight loss medications.

Before starting any GLP-1 therapy, consult with a qualified healthcare provider to ensure these medications are appropriate for your health profile and weight loss goals. Success with GLP-1 medications requires commitment to both the medication regimen and sustainable lifestyle changes for long-term weight management.

Ready to explore your options? Take our free physician assessment to determine if GLP-1 therapy is right for you.

Sources

1. Sequence Weight Loss. Pricing and Plans. Available at: https://www.sequence.com/pricing. Accessed March 2026.
2. Hims & Hers Health. GLP-1 Weight Loss Program. Available at: https://www.hims.com/weight-loss. Accessed March 2026.
3. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216.
4. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002.
5. FDA. Compounding and the FDA: Questions and Answers. Available at: https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers. Accessed March 2026.
6. Trustpilot Reviews: Sequence Weight Loss and Hims & Hers Health. Accessed March 2026.
7. American Society of Clinical Endocrinology. Clinical Practice Guidelines for Obesity Management. Endocr Pract. 2023;29(5):305-324.